MichaelGirardiMD
Dermatology • New Haven, CTProfessor, Dermatology, Yale University School of Medicine
Dr. Girardi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 York St
New Haven, CT 06510Phone+1 203-785-4632Fax+1 203-785-3315
Education & Training
Yale-New Haven Medical CenterResidency, Dermatology, 1994 - 1997- Yale-New Haven Medical CenterInternship, Internal Medicine, 1992 - 1993
Yale School of MedicineClass of 1992
Brown UniversityBS & BA, Biology & Computer Science, Magna Cum Laude, 1984 - 1988
Certifications & Licensure
CT State Medical License 1997 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2008
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Sunscreen Based on Bioadhesive Nanoparticles Start of enrollment: 2017 Jul 17
- A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) Start of enrollment: 2020 Jan 15
Publications & Presentations
PubMed
- 201 citationsCommensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupusTeri M. Greiling, Carina Dehner, Xinguo Chen, Kevin Hughes, Alonso J. Iñiguez
Science Translational Medicine. 2018-03-28 - 228 citationsSkint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal γδ T cellsLynn M. Boyden, Julia M. Lewis, Susannah D Barbee, Anna Bas, Michael Girardi
Nature Genetics. 2008-05-01 - 165 citationsClinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy.Veronica J. Shi, Nemanja Rodić, Scott N. Gettinger, Jonathan S. Leventhal, Julia Pettersen Neckman
JAMA Dermatology. 2016-10-01
Journal Articles
- Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research—ReplyMichael Girardi, MD, JAMA Dermatology
- Evaluation of Lymph Node Ratio Association with Long-Term Patient Survival After Surgery for Node-Positive Merkel Cell CarcinomaMichael Girardi, Shayan Cheraghlou, JAMA
Authored Content
- Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research—ReplyJune 2020
Press Mentions
2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- For the Best Melanoma Prognosis, Location MattersApril 2nd, 2021
- Join now to see all
Grant Support
- Local Immunoregulation Of CarcinogenesisNational Cancer Institute2010–2011
- T Cell Regulation Of Cutaneous MalignancyNational Cancer Institute2003–2007
- TCR DNA Immunization For 2b411 T Cell LymphomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
